1. Fecal calprotectin (FC) level was strongly associated with disease activity indices, serologic markers, and endoscopic activity in patients with inflammatory bowel disease. 2. In particular, calprotectin assays could predict mucosal healing with high sensitivity (> 81%) and specificity (100%) in ulcerative colitis patients. Therefore, FC may be a useful alternative to repeated endoscopies. 3. Quantitative point-of care test can be used more conveniently than enzyme-linked immunosorbent assay to assess FC in clinical practice.
1. The IBD-KNOW (Inflammatory Bowel Disease Knowledge), a novel assessment tool of inflammatory bowel disease (IBD)-related knowledge, demonstrated excellent test characteristics compared with outdated Crohn’s and Colitis Knowledge score. 2. Hospitalization history, education level, and information acquired from patient organization play an important role in correct IBD-related knowledge.
1. Olmesartan use does not increase the risk of intestinal malabsorption in the general Korean population compared to angiotensin converting enzyme (ACE) inhibitor use. 2. Olmesartan use was not associated with the significant body weight loss in the general Koean population compared to ACE inhibitor use.
1. Our single-center study demonstrated the safety of pacemakers or implantable cardioverter defibrillators for 1.5-T magnetic resonance imaging (MRI) scans regardless of whether magnetic resonance-conditional or conventional devices were used. 2. Despite the small study population, our study enrolled variable cases representative of real clinical practice, such as cases of MRI being performed more than twice and performed without mode changes
1. Among nonpulmonary organ dysfunctions, central nervous system dysfunction and coagulopathy were independent risk factors for the development of acute respiratory distress syndrome (ARDS) in patients with bacteremia sepsis. 2. The development of ARDS was significantly associated with an increase in 28-day mortality in patients with bacteremic sepsis.